Clinical Study Results
Research Sponsor: Pearl Therapeutics, Inc.
Drugs studied: Budesonide, Glycopyrronium, and Formoterol Fumarate
Study Title: A study to learn how budesonide, glycopyrronium, and
formoterol fumarate taken together in different ways act
in the body
Thank you!
Thank you to the participants who took part in the clinical trial for the study drugs
budesonide, glycopyrronium, and formoterol fumarate.
Pearl Therapeutics, Inc. sponsored this study and thinks it is important to share the
results. An independent, non-profit organization called CISCRP helped prepare this
summary of the study results for you.
If you participated in this study and have questions about the results, please speak
with the doctor or staff at your study site.
What is happening with the study now?
The participants were in the study for about 13 weeks.
The study started in October 2017 and ended in December 2017.
The sponsor reviewed the data collected when the study ended and created
a report of the results. This is a summary of that report.
Why was the research needed?
Researchers are looking for a better way to treat chronic obstructive pulmonary
disease, also known as COPD. Before a treatment can be approved for patients
to take, researchers do clinical studies to find out how safe it is and how it works.
1